O45.009 Premature separation of placenta with coagulation defect, unspecified, unspecified trimester

Name of the Condition

• Premature Separation of Placenta with Coagulation Defect, Unspecified, Unspecified Trimester (O45.009)

Summary

Premature separation of the placenta (abruptio placentae) with coagulation defect, unspecified trimester, refers to the detachment of the placenta from the uterine wall before delivery, accompanied by abnormal blood clotting. This condition can disrupt oxygen and nutrient flow to the fetus and may cause maternal bleeding. It requires prompt medical evaluation and management.

Causes

The exact cause of this condition is often unknown, but it may result from trauma to the abdomen, rapid uterine decompression, or vascular abnormalities in the placenta. Other potential triggers include hypertension or preeclampsia. The coagulation defect may arise from the placental separation itself or pre-existing clotting disorders.

Risk Factors

• Chronic hypertension or preeclampsia.
• Previous placental abruption.
• Trauma to the abdomen.
• Premature rupture of membranes.
• Smoking or substance use during pregnancy.
• Multiple gestation (e.g., twins or triplets).
• Advanced maternal age.
• Pre-existing coagulation disorders.

Symptoms

• Sudden, persistent abdominal or back pain.
• Vaginal bleeding (may be light or heavy).
• Uterine tenderness or rigidity.
• Fetal distress (e.g., decreased movement).
• Signs of shock in severe cases (e.g., dizziness, rapid heart rate).

Diagnosis

Diagnosis is based on clinical presentation, ultrasound imaging to assess placental separation, and laboratory tests to evaluate coagulation status (e.g., platelet count, fibrinogen levels, and clotting time). Clinical findings, such as uterine tenderness or fetal distress, may also guide diagnosis.

Treatment Options

Treatment depends on the severity of the condition and gestational age. Mild cases may involve close monitoring and bed rest, while severe cases may require emergency delivery, blood transfusions, or medications to manage coagulation defects. In some instances, hysterectomy may be necessary to control bleeding.

Prognosis and Follow-Up

Prognosis varies based on the extent of placental separation, gestational age, and maternal/fetal response to treatment. Close follow-up is essential to monitor for complications, such as postpartum hemorrhage or residual coagulation abnormalities. Fetal outcomes depend on the severity of the separation and timely intervention.

Complications

• Severe maternal hemorrhage.
• Fetal hypoxia or death.
• Disseminated intravascular coagulation (DIC).
• Uterine rupture.
• Postpartum infection or anemia.

Lifestyle & Prevention

• Manage chronic conditions like hypertension with prenatal care.
• Avoid abdominal trauma and smoking during pregnancy.
• Attend regular prenatal visits to monitor placental health.
• Report any vaginal bleeding or abdominal pain promptly.

When to Seek Professional Help

Seek immediate medical attention if experiencing sudden abdominal pain, vaginal bleeding, or signs of shock (e.g., dizziness, rapid pulse). Prompt evaluation is critical to assess placental separation and coagulation status.

Tips for Medical Coders

Use O45.009 for cases of premature placental separation with coagulation defect when the trimester is unspecified. Document clinical details, including the presence of coagulation abnormalities and gestational timing, to support accurate coding. Ensure differentiation from other placental complications (e.g., placenta previa) based on clinical findings.